Penwest and Otsuka in third drug delivery tie-up
This article was originally published in Scrip
Executive Summary
Otsuka Pharmaceutical has again tapped Penwest Pharmaceuticals to develop a controlled-release formulation of one of its products. Penwest will apply its TIMERx oral delivery technology to an unidentified compound from the Japanese firm, in return for undisclosed fees and payments. The TIMERx system is based on a hydrophilic polysaccharide matrix which can be engineered to provide varying release rates. It is the third such collaboration between the two companies.